Ligand Pharmaceuticals Inc logo

Ligand Pharmaceuticals Inc

NEW
FRA:LGDN (USA)   Ordinary Shares - Class B
€ 234 -2 (-0.85%) Aug 31
30.39
P/B:
5.85
Market Cap:
€ 4.89B ($ 5.66B)
Enterprise V:
€ 4.68B ($ 5.42B)
Volume:
35.00
Avg Vol (2M):
30.00
Trade In:

Ligand Pharmaceuticals Inc Valuation Measures